Global Citalopram Market Growth (Status and Outlook) 2025-2031
According to this study, the global Citalopram market size will reach US$ million by 2031.
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
United States market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Citalopram players cover H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Citalopram Industry Forecast” looks at past sales and reviews total world Citalopram sales in 2024, providing a comprehensive analysis by region and market sector of projected Citalopram sales for 2025 through 2031. With Citalopram sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Citalopram industry.
This Insight Report provides a comprehensive analysis of the global Citalopram landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Citalopram portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Citalopram market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Citalopram and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Citalopram.
This report presents a comprehensive overview, market shares, and growth opportunities of Citalopram market by product type, application, key players and key regions and countries.
Segmentation by Type:
Citalopram is a selective serotonin reuptake inhibitor (SSRI), a racemate.It can selectively inhibit the 5-ht transporter, block the reuptake of 5-ht by the presynaptic membrane, prolong and increase the effect of 5-ht, and thus produce antidepressant effect.
United States market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Citalopram is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Citalopram players cover H.Lundbeck A/S, Amneal Pharmaceuticals, Aurobindo Pharma, Hetero Drugs, Macleods Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Citalopram Industry Forecast” looks at past sales and reviews total world Citalopram sales in 2024, providing a comprehensive analysis by region and market sector of projected Citalopram sales for 2025 through 2031. With Citalopram sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Citalopram industry.
This Insight Report provides a comprehensive analysis of the global Citalopram landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Citalopram portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Citalopram market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Citalopram and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Citalopram.
This report presents a comprehensive overview, market shares, and growth opportunities of Citalopram market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Solution
- Tablets
- Other
- Depression
- Generalized Anxiety
- Obsessive Compulsive Disorder
- Somatoform Disorder
- Schizophrenia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- H.Lundbeck A/S
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Hetero Drugs
- Macleods Pharmaceuticals
- Silarx Pharmacueticals
- Apotex
- Hikma Pharmaceuticals
- Jubilant Pharma
- Lupin Limited
- Prinston Pharmaceutical
- STI Pharma
- TEVA Pharmaceutical
- Hexal
- Shanghai Great Wall Pharmaceutical
- Wanquan Wante Pharmaceutical
- Northeast Pharmaceutical Group
- Sichuan Kelun Pharmaceutical
- Kunming Jida Pharmaceutical
- Jiangsu Enhua Pharmaceutical
- Southwest Pharmaceutical
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Citalopram Market Size (2020-2031)
2.1.2 Citalopram Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Citalopram by Country/Region (2020, 2024 & 2031)
2.2 Citalopram Segment by Type
2.2.1 Solution
2.2.2 Tablets
2.2.3 Other
2.3 Citalopram Market Size by Type
2.3.1 Citalopram Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Citalopram Market Size Market Share by Type (2020-2025)
2.4 Citalopram Segment by Application
2.4.1 Depression
2.4.2 Generalized Anxiety
2.4.3 Obsessive Compulsive Disorder
2.4.4 Somatoform Disorder
2.4.5 Schizophrenia
2.4.6 Other
2.5 Citalopram Market Size by Application
2.5.1 Citalopram Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Citalopram Market Size Market Share by Application (2020-2025)
3 CITALOPRAM MARKET SIZE BY PLAYER
3.1 Citalopram Market Size Market Share by Player
3.1.1 Global Citalopram Revenue by Player (2020-2025)
3.1.2 Global Citalopram Revenue Market Share by Player (2020-2025)
3.2 Global Citalopram Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CITALOPRAM BY REGION
4.1 Citalopram Market Size by Region (2020-2025)
4.2 Global Citalopram Annual Revenue by Country/Region (2020-2025)
4.3 Americas Citalopram Market Size Growth (2020-2025)
4.4 APAC Citalopram Market Size Growth (2020-2025)
4.5 Europe Citalopram Market Size Growth (2020-2025)
4.6 Middle East & Africa Citalopram Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Citalopram Market Size by Country (2020-2025)
5.2 Americas Citalopram Market Size by Type (2020-2025)
5.3 Americas Citalopram Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Citalopram Market Size by Region (2020-2025)
6.2 APAC Citalopram Market Size by Type (2020-2025)
6.3 APAC Citalopram Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Citalopram Market Size by Country (2020-2025)
7.2 Europe Citalopram Market Size by Type (2020-2025)
7.3 Europe Citalopram Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Citalopram by Region (2020-2025)
8.2 Middle East & Africa Citalopram Market Size by Type (2020-2025)
8.3 Middle East & Africa Citalopram Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CITALOPRAM MARKET FORECAST
10.1 Global Citalopram Forecast by Region (2026-2031)
10.1.1 Global Citalopram Forecast by Region (2026-2031)
10.1.2 Americas Citalopram Forecast
10.1.3 APAC Citalopram Forecast
10.1.4 Europe Citalopram Forecast
10.1.5 Middle East & Africa Citalopram Forecast
10.2 Americas Citalopram Forecast by Country (2026-2031)
10.2.1 United States Market Citalopram Forecast
10.2.2 Canada Market Citalopram Forecast
10.2.3 Mexico Market Citalopram Forecast
10.2.4 Brazil Market Citalopram Forecast
10.3 APAC Citalopram Forecast by Region (2026-2031)
10.3.1 China Citalopram Market Forecast
10.3.2 Japan Market Citalopram Forecast
10.3.3 Korea Market Citalopram Forecast
10.3.4 Southeast Asia Market Citalopram Forecast
10.3.5 India Market Citalopram Forecast
10.3.6 Australia Market Citalopram Forecast
10.4 Europe Citalopram Forecast by Country (2026-2031)
10.4.1 Germany Market Citalopram Forecast
10.4.2 France Market Citalopram Forecast
10.4.3 UK Market Citalopram Forecast
10.4.4 Italy Market Citalopram Forecast
10.4.5 Russia Market Citalopram Forecast
10.5 Middle East & Africa Citalopram Forecast by Region (2026-2031)
10.5.1 Egypt Market Citalopram Forecast
10.5.2 South Africa Market Citalopram Forecast
10.5.3 Israel Market Citalopram Forecast
10.5.4 Turkey Market Citalopram Forecast
10.6 Global Citalopram Forecast by Type (2026-2031)
10.7 Global Citalopram Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Citalopram Forecast
11 KEY PLAYERS ANALYSIS
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Information
11.1.2 H.Lundbeck A/S Citalopram Product Offered
11.1.3 H.Lundbeck A/S Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 H.Lundbeck A/S Main Business Overview
11.1.5 H.Lundbeck A/S Latest Developments
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Information
11.2.2 Amneal Pharmaceuticals Citalopram Product Offered
11.2.3 Amneal Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amneal Pharmaceuticals Main Business Overview
11.2.5 Amneal Pharmaceuticals Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Citalopram Product Offered
11.3.3 Aurobindo Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Information
11.4.2 Hetero Drugs Citalopram Product Offered
11.4.3 Hetero Drugs Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Hetero Drugs Main Business Overview
11.4.5 Hetero Drugs Latest Developments
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Information
11.5.2 Macleods Pharmaceuticals Citalopram Product Offered
11.5.3 Macleods Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Macleods Pharmaceuticals Main Business Overview
11.5.5 Macleods Pharmaceuticals Latest Developments
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Information
11.6.2 Silarx Pharmacueticals Citalopram Product Offered
11.6.3 Silarx Pharmacueticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Silarx Pharmacueticals Main Business Overview
11.6.5 Silarx Pharmacueticals Latest Developments
11.7 Apotex
11.7.1 Apotex Company Information
11.7.2 Apotex Citalopram Product Offered
11.7.3 Apotex Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Apotex Main Business Overview
11.7.5 Apotex Latest Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Citalopram Product Offered
11.8.3 Hikma Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Hikma Pharmaceuticals Main Business Overview
11.8.5 Hikma Pharmaceuticals Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Citalopram Product Offered
11.9.3 Jubilant Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Lupin Limited
11.10.1 Lupin Limited Company Information
11.10.2 Lupin Limited Citalopram Product Offered
11.10.3 Lupin Limited Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lupin Limited Main Business Overview
11.10.5 Lupin Limited Latest Developments
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Information
11.11.2 Prinston Pharmaceutical Citalopram Product Offered
11.11.3 Prinston Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Prinston Pharmaceutical Main Business Overview
11.11.5 Prinston Pharmaceutical Latest Developments
11.12 STI Pharma
11.12.1 STI Pharma Company Information
11.12.2 STI Pharma Citalopram Product Offered
11.12.3 STI Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 STI Pharma Main Business Overview
11.12.5 STI Pharma Latest Developments
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Information
11.13.2 TEVA Pharmaceutical Citalopram Product Offered
11.13.3 TEVA Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TEVA Pharmaceutical Main Business Overview
11.13.5 TEVA Pharmaceutical Latest Developments
11.14 Hexal
11.14.1 Hexal Company Information
11.14.2 Hexal Citalopram Product Offered
11.14.3 Hexal Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Hexal Main Business Overview
11.14.5 Hexal Latest Developments
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Information
11.15.2 Shanghai Great Wall Pharmaceutical Citalopram Product Offered
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Shanghai Great Wall Pharmaceutical Main Business Overview
11.15.5 Shanghai Great Wall Pharmaceutical Latest Developments
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Information
11.16.2 Wanquan Wante Pharmaceutical Citalopram Product Offered
11.16.3 Wanquan Wante Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Wanquan Wante Pharmaceutical Main Business Overview
11.16.5 Wanquan Wante Pharmaceutical Latest Developments
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Information
11.17.2 Northeast Pharmaceutical Group Citalopram Product Offered
11.17.3 Northeast Pharmaceutical Group Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Northeast Pharmaceutical Group Main Business Overview
11.17.5 Northeast Pharmaceutical Group Latest Developments
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Information
11.18.2 Sichuan Kelun Pharmaceutical Citalopram Product Offered
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.18.5 Sichuan Kelun Pharmaceutical Latest Developments
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Information
11.19.2 Kunming Jida Pharmaceutical Citalopram Product Offered
11.19.3 Kunming Jida Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Kunming Jida Pharmaceutical Main Business Overview
11.19.5 Kunming Jida Pharmaceutical Latest Developments
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Information
11.20.2 Jiangsu Enhua Pharmaceutical Citalopram Product Offered
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Jiangsu Enhua Pharmaceutical Main Business Overview
11.20.5 Jiangsu Enhua Pharmaceutical Latest Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Information
11.21.2 Southwest Pharmaceutical Citalopram Product Offered
11.21.3 Southwest Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Southwest Pharmaceutical Main Business Overview
11.21.5 Southwest Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Citalopram Market Size (2020-2031)
2.1.2 Citalopram Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Citalopram by Country/Region (2020, 2024 & 2031)
2.2 Citalopram Segment by Type
2.2.1 Solution
2.2.2 Tablets
2.2.3 Other
2.3 Citalopram Market Size by Type
2.3.1 Citalopram Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Citalopram Market Size Market Share by Type (2020-2025)
2.4 Citalopram Segment by Application
2.4.1 Depression
2.4.2 Generalized Anxiety
2.4.3 Obsessive Compulsive Disorder
2.4.4 Somatoform Disorder
2.4.5 Schizophrenia
2.4.6 Other
2.5 Citalopram Market Size by Application
2.5.1 Citalopram Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Citalopram Market Size Market Share by Application (2020-2025)
3 CITALOPRAM MARKET SIZE BY PLAYER
3.1 Citalopram Market Size Market Share by Player
3.1.1 Global Citalopram Revenue by Player (2020-2025)
3.1.2 Global Citalopram Revenue Market Share by Player (2020-2025)
3.2 Global Citalopram Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CITALOPRAM BY REGION
4.1 Citalopram Market Size by Region (2020-2025)
4.2 Global Citalopram Annual Revenue by Country/Region (2020-2025)
4.3 Americas Citalopram Market Size Growth (2020-2025)
4.4 APAC Citalopram Market Size Growth (2020-2025)
4.5 Europe Citalopram Market Size Growth (2020-2025)
4.6 Middle East & Africa Citalopram Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Citalopram Market Size by Country (2020-2025)
5.2 Americas Citalopram Market Size by Type (2020-2025)
5.3 Americas Citalopram Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Citalopram Market Size by Region (2020-2025)
6.2 APAC Citalopram Market Size by Type (2020-2025)
6.3 APAC Citalopram Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Citalopram Market Size by Country (2020-2025)
7.2 Europe Citalopram Market Size by Type (2020-2025)
7.3 Europe Citalopram Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Citalopram by Region (2020-2025)
8.2 Middle East & Africa Citalopram Market Size by Type (2020-2025)
8.3 Middle East & Africa Citalopram Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CITALOPRAM MARKET FORECAST
10.1 Global Citalopram Forecast by Region (2026-2031)
10.1.1 Global Citalopram Forecast by Region (2026-2031)
10.1.2 Americas Citalopram Forecast
10.1.3 APAC Citalopram Forecast
10.1.4 Europe Citalopram Forecast
10.1.5 Middle East & Africa Citalopram Forecast
10.2 Americas Citalopram Forecast by Country (2026-2031)
10.2.1 United States Market Citalopram Forecast
10.2.2 Canada Market Citalopram Forecast
10.2.3 Mexico Market Citalopram Forecast
10.2.4 Brazil Market Citalopram Forecast
10.3 APAC Citalopram Forecast by Region (2026-2031)
10.3.1 China Citalopram Market Forecast
10.3.2 Japan Market Citalopram Forecast
10.3.3 Korea Market Citalopram Forecast
10.3.4 Southeast Asia Market Citalopram Forecast
10.3.5 India Market Citalopram Forecast
10.3.6 Australia Market Citalopram Forecast
10.4 Europe Citalopram Forecast by Country (2026-2031)
10.4.1 Germany Market Citalopram Forecast
10.4.2 France Market Citalopram Forecast
10.4.3 UK Market Citalopram Forecast
10.4.4 Italy Market Citalopram Forecast
10.4.5 Russia Market Citalopram Forecast
10.5 Middle East & Africa Citalopram Forecast by Region (2026-2031)
10.5.1 Egypt Market Citalopram Forecast
10.5.2 South Africa Market Citalopram Forecast
10.5.3 Israel Market Citalopram Forecast
10.5.4 Turkey Market Citalopram Forecast
10.6 Global Citalopram Forecast by Type (2026-2031)
10.7 Global Citalopram Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Citalopram Forecast
11 KEY PLAYERS ANALYSIS
11.1 H.Lundbeck A/S
11.1.1 H.Lundbeck A/S Company Information
11.1.2 H.Lundbeck A/S Citalopram Product Offered
11.1.3 H.Lundbeck A/S Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 H.Lundbeck A/S Main Business Overview
11.1.5 H.Lundbeck A/S Latest Developments
11.2 Amneal Pharmaceuticals
11.2.1 Amneal Pharmaceuticals Company Information
11.2.2 Amneal Pharmaceuticals Citalopram Product Offered
11.2.3 Amneal Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Amneal Pharmaceuticals Main Business Overview
11.2.5 Amneal Pharmaceuticals Latest Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Citalopram Product Offered
11.3.3 Aurobindo Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Aurobindo Pharma Main Business Overview
11.3.5 Aurobindo Pharma Latest Developments
11.4 Hetero Drugs
11.4.1 Hetero Drugs Company Information
11.4.2 Hetero Drugs Citalopram Product Offered
11.4.3 Hetero Drugs Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Hetero Drugs Main Business Overview
11.4.5 Hetero Drugs Latest Developments
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Information
11.5.2 Macleods Pharmaceuticals Citalopram Product Offered
11.5.3 Macleods Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Macleods Pharmaceuticals Main Business Overview
11.5.5 Macleods Pharmaceuticals Latest Developments
11.6 Silarx Pharmacueticals
11.6.1 Silarx Pharmacueticals Company Information
11.6.2 Silarx Pharmacueticals Citalopram Product Offered
11.6.3 Silarx Pharmacueticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Silarx Pharmacueticals Main Business Overview
11.6.5 Silarx Pharmacueticals Latest Developments
11.7 Apotex
11.7.1 Apotex Company Information
11.7.2 Apotex Citalopram Product Offered
11.7.3 Apotex Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Apotex Main Business Overview
11.7.5 Apotex Latest Developments
11.8 Hikma Pharmaceuticals
11.8.1 Hikma Pharmaceuticals Company Information
11.8.2 Hikma Pharmaceuticals Citalopram Product Offered
11.8.3 Hikma Pharmaceuticals Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Hikma Pharmaceuticals Main Business Overview
11.8.5 Hikma Pharmaceuticals Latest Developments
11.9 Jubilant Pharma
11.9.1 Jubilant Pharma Company Information
11.9.2 Jubilant Pharma Citalopram Product Offered
11.9.3 Jubilant Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Jubilant Pharma Main Business Overview
11.9.5 Jubilant Pharma Latest Developments
11.10 Lupin Limited
11.10.1 Lupin Limited Company Information
11.10.2 Lupin Limited Citalopram Product Offered
11.10.3 Lupin Limited Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Lupin Limited Main Business Overview
11.10.5 Lupin Limited Latest Developments
11.11 Prinston Pharmaceutical
11.11.1 Prinston Pharmaceutical Company Information
11.11.2 Prinston Pharmaceutical Citalopram Product Offered
11.11.3 Prinston Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Prinston Pharmaceutical Main Business Overview
11.11.5 Prinston Pharmaceutical Latest Developments
11.12 STI Pharma
11.12.1 STI Pharma Company Information
11.12.2 STI Pharma Citalopram Product Offered
11.12.3 STI Pharma Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 STI Pharma Main Business Overview
11.12.5 STI Pharma Latest Developments
11.13 TEVA Pharmaceutical
11.13.1 TEVA Pharmaceutical Company Information
11.13.2 TEVA Pharmaceutical Citalopram Product Offered
11.13.3 TEVA Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 TEVA Pharmaceutical Main Business Overview
11.13.5 TEVA Pharmaceutical Latest Developments
11.14 Hexal
11.14.1 Hexal Company Information
11.14.2 Hexal Citalopram Product Offered
11.14.3 Hexal Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Hexal Main Business Overview
11.14.5 Hexal Latest Developments
11.15 Shanghai Great Wall Pharmaceutical
11.15.1 Shanghai Great Wall Pharmaceutical Company Information
11.15.2 Shanghai Great Wall Pharmaceutical Citalopram Product Offered
11.15.3 Shanghai Great Wall Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.15.4 Shanghai Great Wall Pharmaceutical Main Business Overview
11.15.5 Shanghai Great Wall Pharmaceutical Latest Developments
11.16 Wanquan Wante Pharmaceutical
11.16.1 Wanquan Wante Pharmaceutical Company Information
11.16.2 Wanquan Wante Pharmaceutical Citalopram Product Offered
11.16.3 Wanquan Wante Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.16.4 Wanquan Wante Pharmaceutical Main Business Overview
11.16.5 Wanquan Wante Pharmaceutical Latest Developments
11.17 Northeast Pharmaceutical Group
11.17.1 Northeast Pharmaceutical Group Company Information
11.17.2 Northeast Pharmaceutical Group Citalopram Product Offered
11.17.3 Northeast Pharmaceutical Group Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.17.4 Northeast Pharmaceutical Group Main Business Overview
11.17.5 Northeast Pharmaceutical Group Latest Developments
11.18 Sichuan Kelun Pharmaceutical
11.18.1 Sichuan Kelun Pharmaceutical Company Information
11.18.2 Sichuan Kelun Pharmaceutical Citalopram Product Offered
11.18.3 Sichuan Kelun Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.18.4 Sichuan Kelun Pharmaceutical Main Business Overview
11.18.5 Sichuan Kelun Pharmaceutical Latest Developments
11.19 Kunming Jida Pharmaceutical
11.19.1 Kunming Jida Pharmaceutical Company Information
11.19.2 Kunming Jida Pharmaceutical Citalopram Product Offered
11.19.3 Kunming Jida Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.19.4 Kunming Jida Pharmaceutical Main Business Overview
11.19.5 Kunming Jida Pharmaceutical Latest Developments
11.20 Jiangsu Enhua Pharmaceutical
11.20.1 Jiangsu Enhua Pharmaceutical Company Information
11.20.2 Jiangsu Enhua Pharmaceutical Citalopram Product Offered
11.20.3 Jiangsu Enhua Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.20.4 Jiangsu Enhua Pharmaceutical Main Business Overview
11.20.5 Jiangsu Enhua Pharmaceutical Latest Developments
11.21 Southwest Pharmaceutical
11.21.1 Southwest Pharmaceutical Company Information
11.21.2 Southwest Pharmaceutical Citalopram Product Offered
11.21.3 Southwest Pharmaceutical Citalopram Revenue, Gross Margin and Market Share (2020-2025)
11.21.4 Southwest Pharmaceutical Main Business Overview
11.21.5 Southwest Pharmaceutical Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Citalopram Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Citalopram Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players ofTablets
Table 5. Major Players of Other
Table 6. Citalopram Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Citalopram Market Size Market Share by Type (2020-2025)
Table 9. Citalopram Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Citalopram Market Size Market Share by Application (2020-2025)
Table 12. Global Citalopram Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Citalopram Revenue Market Share by Player (2020-2025)
Table 14. Citalopram Key Players Head office and Products Offered
Table 15. Citalopram Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Citalopram Market Size Market Share by Region (2020-2025)
Table 20. Global Citalopram Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Citalopram Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Citalopram Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Citalopram Market Size Market Share by Country (2020-2025)
Table 24. Americas Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Citalopram Market Size Market Share by Type (2020-2025)
Table 26. Americas Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Citalopram Market Size Market Share by Application (2020-2025)
Table 28. APAC Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Citalopram Market Size Market Share by Region (2020-2025)
Table 30. APAC Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Citalopram Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Citalopram Market Size Market Share by Country (2020-2025)
Table 34. Europe Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Citalopram
Table 40. Key Market Challenges & Risks of Citalopram
Table 41. Key Industry Trends of Citalopram
Table 42. Global Citalopram Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Citalopram Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Citalopram Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Citalopram Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. H.Lundbeck A/S Details, Company Type, Citalopram Area Served and Its Competitors
Table 47. H.Lundbeck A/S Citalopram Product Offered
Table 48. H.Lundbeck A/S Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. H.Lundbeck A/S Main Business
Table 50. H.Lundbeck A/S Latest Developments
Table 51. Amneal Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 52. Amneal Pharmaceuticals Citalopram Product Offered
Table 53. Amneal Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Amneal Pharmaceuticals Main Business
Table 55. Amneal Pharmaceuticals Latest Developments
Table 56. Aurobindo Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 57. Aurobindo Pharma Citalopram Product Offered
Table 58. Aurobindo Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Aurobindo Pharma Main Business
Table 60. Aurobindo Pharma Latest Developments
Table 61. Hetero Drugs Details, Company Type, Citalopram Area Served and Its Competitors
Table 62. Hetero Drugs Citalopram Product Offered
Table 63. Hetero Drugs Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Hetero Drugs Main Business
Table 65. Hetero Drugs Latest Developments
Table 66. Macleods Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 67. Macleods Pharmaceuticals Citalopram Product Offered
Table 68. Macleods Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Macleods Pharmaceuticals Main Business
Table 70. Macleods Pharmaceuticals Latest Developments
Table 71. Silarx Pharmacueticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 72. Silarx Pharmacueticals Citalopram Product Offered
Table 73. Silarx Pharmacueticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Silarx Pharmacueticals Main Business
Table 75. Silarx Pharmacueticals Latest Developments
Table 76. Apotex Details, Company Type, Citalopram Area Served and Its Competitors
Table 77. Apotex Citalopram Product Offered
Table 78. Apotex Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Apotex Main Business
Table 80. Apotex Latest Developments
Table 81. Hikma Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 82. Hikma Pharmaceuticals Citalopram Product Offered
Table 83. Hikma Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Hikma Pharmaceuticals Main Business
Table 85. Hikma Pharmaceuticals Latest Developments
Table 86. Jubilant Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 87. Jubilant Pharma Citalopram Product Offered
Table 88. Jubilant Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Jubilant Pharma Main Business
Table 90. Jubilant Pharma Latest Developments
Table 91. Lupin Limited Details, Company Type, Citalopram Area Served and Its Competitors
Table 92. Lupin Limited Citalopram Product Offered
Table 93. Lupin Limited Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Lupin Limited Main Business
Table 95. Lupin Limited Latest Developments
Table 96. Prinston Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 97. Prinston Pharmaceutical Citalopram Product Offered
Table 98. Prinston Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Prinston Pharmaceutical Main Business
Table 100. Prinston Pharmaceutical Latest Developments
Table 101. STI Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 102. STI Pharma Citalopram Product Offered
Table 103. STI Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. STI Pharma Main Business
Table 105. STI Pharma Latest Developments
Table 106. TEVA Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 107. TEVA Pharmaceutical Citalopram Product Offered
Table 108. TEVA Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. TEVA Pharmaceutical Main Business
Table 110. TEVA Pharmaceutical Latest Developments
Table 111. Hexal Details, Company Type, Citalopram Area Served and Its Competitors
Table 112. Hexal Citalopram Product Offered
Table 113. Hexal Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Hexal Main Business
Table 115. Hexal Latest Developments
Table 116. Shanghai Great Wall Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 117. Shanghai Great Wall Pharmaceutical Citalopram Product Offered
Table 118. Shanghai Great Wall Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Shanghai Great Wall Pharmaceutical Main Business
Table 120. Shanghai Great Wall Pharmaceutical Latest Developments
Table 121. Wanquan Wante Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 122. Wanquan Wante Pharmaceutical Citalopram Product Offered
Table 123. Wanquan Wante Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Wanquan Wante Pharmaceutical Main Business
Table 125. Wanquan Wante Pharmaceutical Latest Developments
Table 126. Northeast Pharmaceutical Group Details, Company Type, Citalopram Area Served and Its Competitors
Table 127. Northeast Pharmaceutical Group Citalopram Product Offered
Table 128. Northeast Pharmaceutical Group Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Northeast Pharmaceutical Group Main Business
Table 130. Northeast Pharmaceutical Group Latest Developments
Table 131. Sichuan Kelun Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 132. Sichuan Kelun Pharmaceutical Citalopram Product Offered
Table 133. Sichuan Kelun Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Sichuan Kelun Pharmaceutical Main Business
Table 135. Sichuan Kelun Pharmaceutical Latest Developments
Table 136. Kunming Jida Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 137. Kunming Jida Pharmaceutical Citalopram Product Offered
Table 138. Kunming Jida Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Kunming Jida Pharmaceutical Main Business
Table 140. Kunming Jida Pharmaceutical Latest Developments
Table 141. Jiangsu Enhua Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 142. Jiangsu Enhua Pharmaceutical Citalopram Product Offered
Table 143. Jiangsu Enhua Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Jiangsu Enhua Pharmaceutical Main Business
Table 145. Jiangsu Enhua Pharmaceutical Latest Developments
Table 146. Southwest Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 147. Southwest Pharmaceutical Citalopram Product Offered
Table 148. Southwest Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Southwest Pharmaceutical Main Business
Table 150. Southwest Pharmaceutical Latest Developments
Table 1. Citalopram Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Citalopram Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Solution
Table 4. Major Players ofTablets
Table 5. Major Players of Other
Table 6. Citalopram Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Citalopram Market Size Market Share by Type (2020-2025)
Table 9. Citalopram Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Citalopram Market Size Market Share by Application (2020-2025)
Table 12. Global Citalopram Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Citalopram Revenue Market Share by Player (2020-2025)
Table 14. Citalopram Key Players Head office and Products Offered
Table 15. Citalopram Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Citalopram Market Size Market Share by Region (2020-2025)
Table 20. Global Citalopram Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Citalopram Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Citalopram Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Citalopram Market Size Market Share by Country (2020-2025)
Table 24. Americas Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Citalopram Market Size Market Share by Type (2020-2025)
Table 26. Americas Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Citalopram Market Size Market Share by Application (2020-2025)
Table 28. APAC Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Citalopram Market Size Market Share by Region (2020-2025)
Table 30. APAC Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Citalopram Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Citalopram Market Size Market Share by Country (2020-2025)
Table 34. Europe Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Citalopram Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Citalopram Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Citalopram Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Citalopram
Table 40. Key Market Challenges & Risks of Citalopram
Table 41. Key Industry Trends of Citalopram
Table 42. Global Citalopram Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Citalopram Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Citalopram Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Citalopram Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. H.Lundbeck A/S Details, Company Type, Citalopram Area Served and Its Competitors
Table 47. H.Lundbeck A/S Citalopram Product Offered
Table 48. H.Lundbeck A/S Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. H.Lundbeck A/S Main Business
Table 50. H.Lundbeck A/S Latest Developments
Table 51. Amneal Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 52. Amneal Pharmaceuticals Citalopram Product Offered
Table 53. Amneal Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Amneal Pharmaceuticals Main Business
Table 55. Amneal Pharmaceuticals Latest Developments
Table 56. Aurobindo Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 57. Aurobindo Pharma Citalopram Product Offered
Table 58. Aurobindo Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Aurobindo Pharma Main Business
Table 60. Aurobindo Pharma Latest Developments
Table 61. Hetero Drugs Details, Company Type, Citalopram Area Served and Its Competitors
Table 62. Hetero Drugs Citalopram Product Offered
Table 63. Hetero Drugs Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Hetero Drugs Main Business
Table 65. Hetero Drugs Latest Developments
Table 66. Macleods Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 67. Macleods Pharmaceuticals Citalopram Product Offered
Table 68. Macleods Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Macleods Pharmaceuticals Main Business
Table 70. Macleods Pharmaceuticals Latest Developments
Table 71. Silarx Pharmacueticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 72. Silarx Pharmacueticals Citalopram Product Offered
Table 73. Silarx Pharmacueticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Silarx Pharmacueticals Main Business
Table 75. Silarx Pharmacueticals Latest Developments
Table 76. Apotex Details, Company Type, Citalopram Area Served and Its Competitors
Table 77. Apotex Citalopram Product Offered
Table 78. Apotex Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Apotex Main Business
Table 80. Apotex Latest Developments
Table 81. Hikma Pharmaceuticals Details, Company Type, Citalopram Area Served and Its Competitors
Table 82. Hikma Pharmaceuticals Citalopram Product Offered
Table 83. Hikma Pharmaceuticals Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Hikma Pharmaceuticals Main Business
Table 85. Hikma Pharmaceuticals Latest Developments
Table 86. Jubilant Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 87. Jubilant Pharma Citalopram Product Offered
Table 88. Jubilant Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Jubilant Pharma Main Business
Table 90. Jubilant Pharma Latest Developments
Table 91. Lupin Limited Details, Company Type, Citalopram Area Served and Its Competitors
Table 92. Lupin Limited Citalopram Product Offered
Table 93. Lupin Limited Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 94. Lupin Limited Main Business
Table 95. Lupin Limited Latest Developments
Table 96. Prinston Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 97. Prinston Pharmaceutical Citalopram Product Offered
Table 98. Prinston Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 99. Prinston Pharmaceutical Main Business
Table 100. Prinston Pharmaceutical Latest Developments
Table 101. STI Pharma Details, Company Type, Citalopram Area Served and Its Competitors
Table 102. STI Pharma Citalopram Product Offered
Table 103. STI Pharma Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 104. STI Pharma Main Business
Table 105. STI Pharma Latest Developments
Table 106. TEVA Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 107. TEVA Pharmaceutical Citalopram Product Offered
Table 108. TEVA Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 109. TEVA Pharmaceutical Main Business
Table 110. TEVA Pharmaceutical Latest Developments
Table 111. Hexal Details, Company Type, Citalopram Area Served and Its Competitors
Table 112. Hexal Citalopram Product Offered
Table 113. Hexal Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 114. Hexal Main Business
Table 115. Hexal Latest Developments
Table 116. Shanghai Great Wall Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 117. Shanghai Great Wall Pharmaceutical Citalopram Product Offered
Table 118. Shanghai Great Wall Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 119. Shanghai Great Wall Pharmaceutical Main Business
Table 120. Shanghai Great Wall Pharmaceutical Latest Developments
Table 121. Wanquan Wante Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 122. Wanquan Wante Pharmaceutical Citalopram Product Offered
Table 123. Wanquan Wante Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 124. Wanquan Wante Pharmaceutical Main Business
Table 125. Wanquan Wante Pharmaceutical Latest Developments
Table 126. Northeast Pharmaceutical Group Details, Company Type, Citalopram Area Served and Its Competitors
Table 127. Northeast Pharmaceutical Group Citalopram Product Offered
Table 128. Northeast Pharmaceutical Group Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 129. Northeast Pharmaceutical Group Main Business
Table 130. Northeast Pharmaceutical Group Latest Developments
Table 131. Sichuan Kelun Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 132. Sichuan Kelun Pharmaceutical Citalopram Product Offered
Table 133. Sichuan Kelun Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 134. Sichuan Kelun Pharmaceutical Main Business
Table 135. Sichuan Kelun Pharmaceutical Latest Developments
Table 136. Kunming Jida Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 137. Kunming Jida Pharmaceutical Citalopram Product Offered
Table 138. Kunming Jida Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 139. Kunming Jida Pharmaceutical Main Business
Table 140. Kunming Jida Pharmaceutical Latest Developments
Table 141. Jiangsu Enhua Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 142. Jiangsu Enhua Pharmaceutical Citalopram Product Offered
Table 143. Jiangsu Enhua Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 144. Jiangsu Enhua Pharmaceutical Main Business
Table 145. Jiangsu Enhua Pharmaceutical Latest Developments
Table 146. Southwest Pharmaceutical Details, Company Type, Citalopram Area Served and Its Competitors
Table 147. Southwest Pharmaceutical Citalopram Product Offered
Table 148. Southwest Pharmaceutical Citalopram Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 149. Southwest Pharmaceutical Main Business
Table 150. Southwest Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Citalopram Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Citalopram Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Citalopram Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Citalopram Sales Market Share by Country/Region (2024)
Figure 8. Citalopram Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Citalopram Market Size Market Share by Type in 2024
Figure 10. Citalopram in Depression
Figure 11. Global Citalopram Market: Depression (2020-2025) & ($ millions)
Figure 12. Citalopram in Generalized Anxiety
Figure 13. Global Citalopram Market: Generalized Anxiety (2020-2025) & ($ millions)
Figure 14. Citalopram in Obsessive Compulsive Disorder
Figure 15. Global Citalopram Market: Obsessive Compulsive Disorder (2020-2025) & ($ millions)
Figure 16. Citalopram in Somatoform Disorder
Figure 17. Global Citalopram Market: Somatoform Disorder (2020-2025) & ($ millions)
Figure 18. Citalopram in Schizophrenia
Figure 19. Global Citalopram Market: Schizophrenia (2020-2025) & ($ millions)
Figure 20. Citalopram in Other
Figure 21. Global Citalopram Market: Other (2020-2025) & ($ millions)
Figure 22. Global Citalopram Market Size Market Share by Application in 2024
Figure 23. Global Citalopram Revenue Market Share by Player in 2024
Figure 24. Global Citalopram Market Size Market Share by Region (2020-2025)
Figure 25. Americas Citalopram Market Size 2020-2025 ($ millions)
Figure 26. APAC Citalopram Market Size 2020-2025 ($ millions)
Figure 27. Europe Citalopram Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Citalopram Market Size 2020-2025 ($ millions)
Figure 29. Americas Citalopram Value Market Share by Country in 2024
Figure 30. United States Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Citalopram Market Size Market Share by Region in 2024
Figure 35. APAC Citalopram Market Size Market Share by Type (2020-2025)
Figure 36. APAC Citalopram Market Size Market Share by Application (2020-2025)
Figure 37. China Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 41. India Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Citalopram Market Size Market Share by Country in 2024
Figure 44. Europe Citalopram Market Size Market Share by Type (2020-2025)
Figure 45. Europe Citalopram Market Size Market Share by Application (2020-2025)
Figure 46. Germany Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 47. France Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Citalopram Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Citalopram Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Citalopram Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Citalopram Market Size 2026-2031 ($ millions)
Figure 60. APAC Citalopram Market Size 2026-2031 ($ millions)
Figure 61. Europe Citalopram Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Citalopram Market Size 2026-2031 ($ millions)
Figure 63. United States Citalopram Market Size 2026-2031 ($ millions)
Figure 64. Canada Citalopram Market Size 2026-2031 ($ millions)
Figure 65. Mexico Citalopram Market Size 2026-2031 ($ millions)
Figure 66. Brazil Citalopram Market Size 2026-2031 ($ millions)
Figure 67. China Citalopram Market Size 2026-2031 ($ millions)
Figure 68. Japan Citalopram Market Size 2026-2031 ($ millions)
Figure 69. Korea Citalopram Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Citalopram Market Size 2026-2031 ($ millions)
Figure 71. India Citalopram Market Size 2026-2031 ($ millions)
Figure 72. Australia Citalopram Market Size 2026-2031 ($ millions)
Figure 73. Germany Citalopram Market Size 2026-2031 ($ millions)
Figure 74. France Citalopram Market Size 2026-2031 ($ millions)
Figure 75. UK Citalopram Market Size 2026-2031 ($ millions)
Figure 76. Italy Citalopram Market Size 2026-2031 ($ millions)
Figure 77. Russia Citalopram Market Size 2026-2031 ($ millions)
Figure 78. Egypt Citalopram Market Size 2026-2031 ($ millions)
Figure 79. South Africa Citalopram Market Size 2026-2031 ($ millions)
Figure 80. Israel Citalopram Market Size 2026-2031 ($ millions)
Figure 81. Turkey Citalopram Market Size 2026-2031 ($ millions)
Figure 82. Global Citalopram Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Citalopram Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Citalopram Market Size 2026-2031 ($ millions)
Figure 1. Citalopram Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Citalopram Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Citalopram Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Citalopram Sales Market Share by Country/Region (2024)
Figure 8. Citalopram Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Citalopram Market Size Market Share by Type in 2024
Figure 10. Citalopram in Depression
Figure 11. Global Citalopram Market: Depression (2020-2025) & ($ millions)
Figure 12. Citalopram in Generalized Anxiety
Figure 13. Global Citalopram Market: Generalized Anxiety (2020-2025) & ($ millions)
Figure 14. Citalopram in Obsessive Compulsive Disorder
Figure 15. Global Citalopram Market: Obsessive Compulsive Disorder (2020-2025) & ($ millions)
Figure 16. Citalopram in Somatoform Disorder
Figure 17. Global Citalopram Market: Somatoform Disorder (2020-2025) & ($ millions)
Figure 18. Citalopram in Schizophrenia
Figure 19. Global Citalopram Market: Schizophrenia (2020-2025) & ($ millions)
Figure 20. Citalopram in Other
Figure 21. Global Citalopram Market: Other (2020-2025) & ($ millions)
Figure 22. Global Citalopram Market Size Market Share by Application in 2024
Figure 23. Global Citalopram Revenue Market Share by Player in 2024
Figure 24. Global Citalopram Market Size Market Share by Region (2020-2025)
Figure 25. Americas Citalopram Market Size 2020-2025 ($ millions)
Figure 26. APAC Citalopram Market Size 2020-2025 ($ millions)
Figure 27. Europe Citalopram Market Size 2020-2025 ($ millions)
Figure 28. Middle East & Africa Citalopram Market Size 2020-2025 ($ millions)
Figure 29. Americas Citalopram Value Market Share by Country in 2024
Figure 30. United States Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 31. Canada Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 32. Mexico Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 33. Brazil Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 34. APAC Citalopram Market Size Market Share by Region in 2024
Figure 35. APAC Citalopram Market Size Market Share by Type (2020-2025)
Figure 36. APAC Citalopram Market Size Market Share by Application (2020-2025)
Figure 37. China Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 38. Japan Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 39. South Korea Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 40. Southeast Asia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 41. India Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 42. Australia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 43. Europe Citalopram Market Size Market Share by Country in 2024
Figure 44. Europe Citalopram Market Size Market Share by Type (2020-2025)
Figure 45. Europe Citalopram Market Size Market Share by Application (2020-2025)
Figure 46. Germany Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 47. France Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 48. UK Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 49. Italy Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 50. Russia Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 51. Middle East & Africa Citalopram Market Size Market Share by Region (2020-2025)
Figure 52. Middle East & Africa Citalopram Market Size Market Share by Type (2020-2025)
Figure 53. Middle East & Africa Citalopram Market Size Market Share by Application (2020-2025)
Figure 54. Egypt Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 55. South Africa Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 56. Israel Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 57. Turkey Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 58. GCC Countries Citalopram Market Size Growth 2020-2025 ($ millions)
Figure 59. Americas Citalopram Market Size 2026-2031 ($ millions)
Figure 60. APAC Citalopram Market Size 2026-2031 ($ millions)
Figure 61. Europe Citalopram Market Size 2026-2031 ($ millions)
Figure 62. Middle East & Africa Citalopram Market Size 2026-2031 ($ millions)
Figure 63. United States Citalopram Market Size 2026-2031 ($ millions)
Figure 64. Canada Citalopram Market Size 2026-2031 ($ millions)
Figure 65. Mexico Citalopram Market Size 2026-2031 ($ millions)
Figure 66. Brazil Citalopram Market Size 2026-2031 ($ millions)
Figure 67. China Citalopram Market Size 2026-2031 ($ millions)
Figure 68. Japan Citalopram Market Size 2026-2031 ($ millions)
Figure 69. Korea Citalopram Market Size 2026-2031 ($ millions)
Figure 70. Southeast Asia Citalopram Market Size 2026-2031 ($ millions)
Figure 71. India Citalopram Market Size 2026-2031 ($ millions)
Figure 72. Australia Citalopram Market Size 2026-2031 ($ millions)
Figure 73. Germany Citalopram Market Size 2026-2031 ($ millions)
Figure 74. France Citalopram Market Size 2026-2031 ($ millions)
Figure 75. UK Citalopram Market Size 2026-2031 ($ millions)
Figure 76. Italy Citalopram Market Size 2026-2031 ($ millions)
Figure 77. Russia Citalopram Market Size 2026-2031 ($ millions)
Figure 78. Egypt Citalopram Market Size 2026-2031 ($ millions)
Figure 79. South Africa Citalopram Market Size 2026-2031 ($ millions)
Figure 80. Israel Citalopram Market Size 2026-2031 ($ millions)
Figure 81. Turkey Citalopram Market Size 2026-2031 ($ millions)
Figure 82. Global Citalopram Market Size Market Share Forecast by Type (2026-2031)
Figure 83. Global Citalopram Market Size Market Share Forecast by Application (2026-2031)
Figure 84. GCC Countries Citalopram Market Size 2026-2031 ($ millions)
More Publications
Global Behavioral Health Software Market Growth (Status and Outlook) 2025-2031
US$ 3,660.00
March 2025
151 pages
Global Raising Slings Market Growth 2023-2029
US$ 3,660.00
March 2023
101 pages
Global Sensor Based Glucose Measuring System Market Growth 2024-2030
US$ 3,660.00
December 2024
94 pages
Global Oral Irrigator Market Growth 2026-2032
US$ 3,660.00
July 2026
114 pages
Global Pharmaceutical Track and Trace System Market Growth (Status and Outlook) 2026-2032
US$ 3,660.00
January 2026
108 pages
